https://www.selleckchem.com/products/Nolvadex.html
DCA illustrated that when the threshold probability was 8%-90%, the predictive model provided a net benefit relative to the intervention-all or the intervention-none strategy, indicating that the nomogram had favorable potential clinical utility. This nomogram will be an available tool to quantify the risk of neutropenia after chemotherapy in patients who suffer from NSCLC and deserves further external validation. This nomogram will be an available tool to quantify the risk of neutropenia after chemotherapy in patients who suffer from